ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,409,000 | +25.1% | 1,020,748 | 0.0% | 0.03% | +78.9% |
| Q2 2021 | $2,725,000 | +24.8% | 1,020,748 | 0.0% | 0.02% | -24.0% |
| Q1 2021 | $2,184,000 | -13.4% | 1,020,748 | 0.0% | 0.02% | -10.7% |
| Q4 2020 | $2,521,000 | +21.1% | 1,020,748 | 0.0% | 0.03% | -24.3% |
| Q3 2020 | $2,082,000 | -31.1% | 1,020,748 | 0.0% | 0.04% | -30.2% |
| Q2 2020 | $3,021,000 | +12.0% | 1,020,748 | 0.0% | 0.05% | -14.5% |
| Q1 2020 | $2,698,000 | -46.8% | 1,020,748 | 0.0% | 0.06% | -17.3% |
| Q4 2019 | $5,073,000 | -58.3% | 1,020,748 | -50.0% | 0.08% | -16.7% |
| Q3 2019 | $12,168,000 | +84.8% | 2,041,496 | +100.0% | 0.09% | -9.1% |
| Q2 2019 | $6,584,000 | -4.6% | 1,020,748 | 0.0% | 0.10% | -27.2% |
| Q1 2019 | $6,900,000 | +66.1% | 1,020,748 | 0.0% | 0.14% | +103.0% |
| Q4 2018 | $4,154,000 | -62.6% | 1,020,748 | 0.0% | 0.07% | -52.5% |
| Q3 2018 | $11,106,000 | – | 1,020,748 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
| Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
| Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
| Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
| Granahan Investment Management | 141,012 | $840,000 | 0.05% |
| Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
| BlackRock Inc. | 15,755 | $94,000 | 0.00% |